{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T07:31:13Z","timestamp":1694590273726},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"S3","license":[{"start":{"date-parts":[[2008,10,18]],"date-time":"2008-10-18T00:00:00Z","timestamp":1224288000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1007\/s00115-008-2498-y","type":"journal-article","created":{"date-parts":[[2008,10,18]],"date-time":"2008-10-18T17:16:06Z","timestamp":1224350166000},"page":"139-148","source":"Crossref","is-referenced-by-count":2,"title":["Neue Perspektiven in der laborchemischen Diagnostik bei Demenzen","New perspectives in the laboratory diagnosis of dementia"],"prefix":"10.1007","volume":"79","author":[{"given":"M.","family":"Bibl","sequence":"first","affiliation":[]},{"given":"J.","family":"Wiltfang","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2008,10,18]]},"reference":[{"key":"2498_CR1","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1586\/14789450.5.2.153","volume":"5","author":"Bibl","year":"2008","unstructured":"Bibl M, Wiltfang J (2008) Diagnostic and prognostic needs in neurodegenerative diseases: focus on proteomics. Expert Rev Proteomics 5: 153\u2013156","journal-title":"Expert Rev Proteomics"},{"key":"2498_CR2","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1093\/brain\/awl063","volume":"129","author":"Bibl","year":"2006","unstructured":"Bibl M, Mollenhauer B, Esselmann H et al. (2006) CSF amyloid-\u03b2-peptides in Alzheimer\u2019s disease, dementia with Lewy bodies and Parkinson\u2019s disease dementia. Brain 129: 1177\u20131187","journal-title":"Brain"},{"key":"2498_CR3","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1471-4159.2007.04763.x","volume":"103","author":"Bibl","year":"2007","unstructured":"Bibl M, Esselmann H, Mollenhauer B et al. (2007) Blood-based neurochemical diagnosis of vascular dementia: a pilot study. J Neurochem 103: 467\u2013474","journal-title":"J Neurochem"},{"key":"2498_CR4","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/sj.mp.4001967","volume":"12","author":"Bibl","year":"2007","unstructured":"Bibl M, Mollenhauer B, Lewczuk et al. (2007) Validation of amyloid-\u03b2 peptides in CSF diagnosis of neurodegenerative dementias. Mol Psychiatry 12: 671\u2013680","journal-title":"Mol Psychiatry"},{"key":"2498_CR5","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1602\/neurorx.1.2.213","volume":"1","author":"Blennow","year":"2004","unstructured":"Blennow K (2004) Cerebrospinal fluid protein biomarkers for Alzheimer\u2019s disease. NeuroRx 1: 213\u2013225","journal-title":"NeuroRx"},{"key":"2498_CR6","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0140-6736(06)69113-7","volume":"368","author":"Blennow","year":"2006","unstructured":"Blennow K, Leon MJ de, Zetterberg H (2006) Alzheimer\u2019s disease. Lancet 368: 387\u2013403","journal-title":"Lancet"},{"key":"2498_CR7","unstructured":"Brodaty H (2006) The right to know and the right not to know: truth telling and dementia. Lecture, Congress of Alzheimer\u2019s Disease International, Berlin, 12.\u201314. October"},{"key":"2498_CR8","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0165-0173(00)00019-9","volume":"33","author":"Buee","year":"2000","unstructured":"Buee L, Bussiere T, Buee-Scherrer V et al. (2000) Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res Brain Res Rev 33: 95\u2013130","journal-title":"Brain Res Brain Res Rev"},{"key":"2498_CR9","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/gerona\/61.7.755","volume":"61","author":"De","year":"2006","unstructured":"De Jong D, Jansen RWMM, Kremer BPH et al. (2006) Cerebrospinal fluid amyloid \u03b242\/phosphorylated tau ratio discriminates between Alzheimer\u2019s disease and vascular dementia. J Gerontol A Biol Sci Med Sci 61: 755\u2013758","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2498_CR10","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/S1474-4422(07)70178-3","volume":"6","author":"Dubios","year":"2007","unstructured":"Dubios B, Feldman HW, Jacova C et al. (2007) Research criteria for the diagnosis of Alzheimer\u2019s disease: revising the NINCDS-ADRDA criteria. Lancet Neurol 6: 734\u2013746","journal-title":"Lancet Neurol"},{"key":"2498_CR11","doi-asserted-by":"crossref","unstructured":"F\u00f6rstl H (2003) Lehrbuch der Gerontopsychiatrie und -psychotherapie, 2. aktual. erw. Aufl. Thieme, Stuttgart New York","DOI":"10.1055\/b-002-11380"},{"key":"2498_CR12","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1159\/000119457","volume":"5","author":"H\u00f6glund","year":"2007","unstructured":"H\u00f6glund K, Hansson O, Buchhave P et al. (2007) Prediction of Alzheimer\u2019s disease using a cerebrospinal fluid pattern of C-terminally truncated \u03b2-amyloid peptides. Neurodegen Dis 5: 268\u2013276","journal-title":"Neurodegen Dis"},{"key":"2498_CR13","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1093\/brain\/awl280","volume":"129","author":"Klafki","year":"2006","unstructured":"Klafki HW, Staufenbiel M, Kornhuber J et al. (2006) Therapeutic approaches to Alzheimer\u2019s disease. Brain 129: 2840\u20132855","journal-title":"Brain"},{"key":"2498_CR14","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1001\/archneur.60.9.1202","volume":"60","author":"Maddalena","year":"2003","unstructured":"Maddalena A, Papassotiropoulos A, Mueller-Tillmanns B et al. (2003) Cerebrospinal fluid amyloid \u03b242\/phosphorylated tau ratio discriminates between Alzheimer\u2019s disease and vascular dementia. Arch Neurol 60: 1202\u20131206","journal-title":"Arch Neurol"},{"key":"2498_CR15","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/nm1653","volume":"13","author":"Ray","year":"2007","unstructured":"Ray S, Britschgi M, Herbert C et al. (2007) Classification and prediction of clinical Alzheimer\u2019s diagnosis based on plasma signaling proteins. Nat Med 13: 1359\u20131362","journal-title":"Nat Med"},{"key":"2498_CR16","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.cca.2005.06.015","volume":"364","author":"Solfrizzi","year":"2006","unstructured":"Solfrizzi V, D\u2019Introno, Colacicco AM et al. (2006) Circulating biomarkers of cognitive decline and dementia. Clin Chim Acta 364: 91\u2013111","journal-title":"Clin Chim Acta"},{"key":"2498_CR17","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S1474-4422(06)70501-4","volume":"5","author":"Van","year":"2006","unstructured":"Van Oijen M, Hofman A, Soares HD et al. (2006) Plasma abeta(1\u201340) and abeta(1\u201342) and the risk of dementia: a prospective case-cohort study. Lancet Neurol 5: 655\u2013660","journal-title":"Lancet Neurol"},{"key":"2498_CR18","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1046\/j.1471-4159.2002.00818.x","volume":"81","author":"Wiltfang","year":"2002","unstructured":"Wiltfang J, Esselmann H, Bibl M et al. (2002) Highly conserved and disease-specific patterns of carboxyterminally truncated abeta peptides 1\u201337\/38\/39 in addition to 1\u201340\/42 in Alzheimer\u2019s disease and in patients with chronic neuroinflammation. J Neurochem 81: 481\u2013496","journal-title":"J Neurochem"},{"key":"2498_CR19","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/j.1471-4159.2006.04404.x","volume":"101","author":"Wiltfang","year":"2007","unstructured":"Wiltfang J, Esselmann H, Bibl M et al. (2007) Amyloid \u03b2 peptide ratio 42\/40 but not A\u03b242 correlates with phospho-Tau in patients with low- and high-CSF A\u03b240 load. J Neurochem 101: 1053\u20131059","journal-title":"J Neurochem"},{"key":"2498_CR20","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0197-4580(98)00022-0","volume":"19","author":"Working","year":"1998","unstructured":"Working Group on Molecular and Biochemical Markers of Alzheimer\u2019s Disease (1998) Consensus report of the Working Group on Molecular and Biochemical Markers of Alzheimer\u2019s Disease. The Ronald and Nancy Reagan Research Institute of the Alzheimer\u2019s Association and the National Institute on Aging Working Group. Neurobiol Aging 19: 109\u2013116","journal-title":"Neurobiol Aging"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-008-2498-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00115-008-2498-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-008-2498-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T16:23:34Z","timestamp":1684599814000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00115-008-2498-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10,18]]},"references-count":20,"journal-issue":{"issue":"S3","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["2498"],"URL":"https:\/\/doi.org\/10.1007\/s00115-008-2498-y","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,10,18]]}}}